Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Johnson & Johnson (NYSE: JNJ) has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The event will take place at the Westin St. Francis in San Francisco, CA, where Joaquin Duato, Chairman and Chief Executive Officer, will represent the company in a session scheduled for 12:00 p.m. (Eastern Time) on Monday, January 13th.
A live audio webcast will be accessible to investors and interested parties through the company's investor website at www.investor.jnj.com. The audio webcast replay will become available approximately 48 hours after the initial broadcast.
Johnson & Johnson (NYSE: JNJ) ha annunciato la sua partecipazione alla 43ª Conferenza Annuale sulla Salute J.P. Morgan. L'evento si terrà presso il Westin St. Francis a San Francisco, CA, dove Joaquin Duato, Presidente e Amministratore Delegato, rappresenterà l'azienda in una sessione programmata per le 12:00 (Eastern Time) di lunedì 13 gennaio.
Un webcast audio in diretta sarà accessibile da parte degli investitori e delle parti interessate attraverso il sito web dedicato agli investitori dell'azienda all'indirizzo www.investor.jnj.com. La registrazione del webcast audio sarà disponibile circa 48 ore dopo la trasmissione iniziale.
Johnson & Johnson (NYSE: JNJ) ha anunciado su participación en la 43ª Conferencia Anual de Salud J.P. Morgan. El evento se llevará a cabo en el Westin St. Francis en San Francisco, CA, donde Joaquin Duato, Presidente y Director Ejecutivo, representará a la compañía en una sesión programada para las 12:00 p.m. (hora del Este) el lunes 13 de enero.
Una transmisión de audio en vivo estará accesible para los inversores y partes interesadas a través del sitio web de inversores de la compañía en www.investor.jnj.com. La repetición del webcast de audio estará disponible aproximadamente 48 horas después de la transmisión inicial.
Johnson & Johnson (NYSE: JNJ)는 제43회 연례 J.P. Morgan 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 샌프란시스코, CA의 웨스틴 세인트 프란시스 호텔에서 열리며, 호아킨 두아토 회장 겸 CEO가 1월 13일 월요일 오후 12시(동부 표준시) 세션에서 회사를 대표할 예정입니다.
실시간 오디오 웹캐스트는 투자자 및 관심 있는 당사자들이 회사의 투자자 웹사이트 www.investor.jnj.com를 통해 접근할 수 있습니다. 오디오 웹캐스트의 재방송은 초기 방송 후 약 48시간 이내에 제공될 예정입니다.
Johnson & Johnson (NYSE: JNJ) a annoncé sa participation à la 43e Conférence Annuelle sur la Santé J.P. Morgan. L'événement se déroulera au Westin St. Francis à San Francisco, CA, où Joaquin Duato, Président et Directeur Général, représentera l'entreprise lors d'une session prévue à 12h00 (heure de l'Est) le lundi 13 janvier.
Un webcast audio en direct sera accessible aux investisseurs et aux parties intéressées via le site web d'investisseurs de l'entreprise à l'adresse www.investor.jnj.com. La rediffusion du webcast audio sera disponible environ 48 heures après la diffusion initiale.
Johnson & Johnson (NYSE: JNJ) hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz angekündigt. Die Veranstaltung findet im Westin St. Francis in San Francisco, CA statt, wo Joaquin Duato, Vorstandsvorsitzender und CEO, das Unternehmen in einer Sitzung vertreten wird, die für Montag, den 13. Januar, um 12:00 Uhr (Eastern Time) angesetzt ist.
Ein Live-Audio-Webcast wird für Investoren und Interessierte über die Investor-Website des Unternehmens unter www.investor.jnj.com zugänglich sein. Die Wiederholung des Audio-Webcasts wird etwa 48 Stunden nach der ursprünglichen Übertragung verfügbar sein.
- None.
- None.
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
The audio webcast replay will be available approximately 48-hrs after the webcast.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241212414962/en/
Media contact:
media-relations@its.jnj.com
Investor contact:
investor-relations@its.jnj.com
Source: Johnson & Johnson
FAQ
When is Johnson & Johnson (JNJ) presenting at the 2024 J.P. Morgan Healthcare Conference?
How can investors access JNJ's presentation at the J.P. Morgan Healthcare Conference?
When will the replay of JNJ's J.P. Morgan Healthcare Conference presentation be available?
Who is representing JNJ at the 2024 J.P. Morgan Healthcare Conference?